Literature DB >> 23304015

Extreme thrombocytosis and cardiovascular surgery: risks and management.

Ethan A Natelson1.   

Abstract

Extreme thrombocytosis is a major risk factor for excessive bleeding and for thrombosis, either of which can complicate cardiovascular surgical and interventional procedures. Extreme thrombocytosis can also cause an unusual syndrome, erythromelalgia, that results in a type of chronic microvascular occlusive arterial disease. We present the differential diagnosis of conditions that may lead to extreme thrombocytosis, 3 cases (each of which illustrates a different potential complication), and a review of the pertinent medical literature. Correcting excessive thrombocytosis is typically not difficult, whether electively or acutely, and effective therapy usually controls thrombosis and excessive hemorrhage post-procedurally.

Entities:  

Keywords:  Coronary thrombosis/prevention & control/surgery; erythromelalgia; hemorrhage/drug therapy; hydroxyurea/therapeutic use; myeloproliferative disorders/genetics/pathology; plateletpheresis; polycythemia vera/blood; preoperative care/methods; risk factors; thrombocythemia, essential/complications/diagnosis/etiology/genetics/metabolism/physiopathology

Mesh:

Substances:

Year:  2012        PMID: 23304015      PMCID: PMC3528235     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  16 in total

1.  Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia.

Authors:  Koushi Yamaguchi; Michi Hisano; Mariko Sakata; Yasuyuki Minatogawa; Teruaki Suzuki; Nobuaki Ozawa; Michihiro Kitagawa; Atsuko Murashima
Journal:  J Clin Apher       Date:  2006-12       Impact factor: 2.821

Review 2.  The pathogenesis of essential thrombocythemia.

Authors:  Philip A Beer
Journal:  Curr Opin Hematol       Date:  2011-09       Impact factor: 3.284

3.  The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.

Authors:  Khadija Abdulkarim; Börje Ridell; Peter Johansson; Jack Kutti; Soodabeh Safai-Kutti; Björn Andréasson
Journal:  Eur J Haematol       Date:  2010-12-22       Impact factor: 2.997

4.  Mitroaortic valve replacement after aortic transapical approach failure in a patient with essential thrombocytosis.

Authors:  Maria A Gutierrez-Martin; Omar A Araji; Nuria Miranda; Jose M Barquero
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-06-11

5.  Cardiac surgery in a patient with essential thrombocythemia: a case report.

Authors:  B E Schölzel; H Endeman; W Dewilde; A Yilmaz; O de Weerdt; J M Ten Berg
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

6.  Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.

Authors:  P Bernasconi; M Boni; P M Cavigliano; S Calatroni; E Brusamolino; F Passamonti; G Volpe; A Pistorio; I Giardini; B Rocca; M Caresana; M Lazzarino; C Bernasconi
Journal:  Leukemia       Date:  2002-10       Impact factor: 11.528

7.  Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.

Authors:  Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

8.  Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.

Authors:  Alexandra P Wolanskyj; Susan M Schwager; Rebecca F McClure; Dirk R Larson; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2006-02       Impact factor: 7.616

9.  Erythromelalgia and livedo reticularis in a patient with essential thrombocythemia, acquired von Willebrand disease, and elevated anti-phospholipid antibodies.

Authors:  Thilo Gambichler; Rebecca Matip
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

10.  Aortic valve replacement in a young patient with essential thrombocytosis.

Authors:  Kashif Ahmed; Hunaid A Vohra; Alison Milne; Stephen M Langley
Journal:  J Cardiothorac Surg       Date:  2008-01-30       Impact factor: 1.637

View more
  1 in total

Review 1.  Disordered haematopoiesis and athero-thrombosis.

Authors:  Andrew J Murphy; Alan R Tall
Journal:  Eur Heart J       Date:  2016-02-10       Impact factor: 29.983

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.